Skip to main content
Figure 3 | Alzheimer's Research & Therapy

Figure 3

From: Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

Figure 3

Mean change in MMSE from baseline (FAS). MMSE, Mini-Mental State Examination; FAS, full-analysis set. (a) PLA-DON10 group started treatment with 3 mg at Week 16, and the dose was increased to 5 mg at Week 18. (b) PLA-DON10 and DON5-DON10 groups started treatment with 10 mg at Week 24 (dose decrease to 5 mg was allowed). *P < 0.05 (paired t test versus Week 0).

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193